Max’s medical drama The Pitt, starring Noah Wyle as a senior E.R. physician, has won over real-life doctors and nurses for its unprecedented realism. Created by ER veteran R. Scott Gemmill and produced by John Wells, the show portrays an intense 15-hour hospital shift in real-time, emphasizing the challenges of modern emergency medicine. Medical professionals, including Dr. Graham Walker, Dr. Elizabeth Rempfer, and Dr. Tricia Pendergrast, have praised its accurate depiction of medical decisions, hospital bureaucracy, and the emotional toll of the job. While some dramatic liberties remain, The Pitt has struck a chord with healthcare workers, offering both validation…
Author: Rutali Thakur
The U.S. Multi-Society Task Force on Colorectal Cancer (ACG, AGA, ASGE) has updated its recommendations for bowel preparation prior to colonoscopy, setting a new benchmark of 90% adequacy for both endoscopists and endoscopy units. Since colonoscopy is the gold standard for detecting colorectal cancer (CRC) and assessing other colonic diseases, ensuring high-quality bowel preparation is essential for improving polyp detection rates and reducing CRC mortality.
Key Takeaways:
Key Findings from the “Closing the Gap: CRC Screening Insights” Survey
As we approach the 100th anniversary of Crohn’s disease first being described, Clinical Gastroenterology and Hepatology (CGH) is diving into the past, present, and future of inflammatory bowel disease (IBD) care. Its special issue covers groundbreaking advancements, ongoing challenges — such as rising treatment costs and the increasing global burden of IBD — and emerging strategies shaping the future of patient care. The special issue comprises a collection of articles selected by authors Edward Loftus, MD, of Mayo Clinic; Joana Torres, MD, of Universidade de Lisboa; Jason Hou, MD, of Baylor University; Charles Kahi, MD, of Indiana University; and Siddharth Singh, MD, of University of…
Fourth quarter and 2024 highlights
From Stark law to prior authorization hurdles, gastroenterologist leaders see three major regulatory obstacles stifling industry growth and innovation. Payer reimbursement William Chey, MD, president-elect of American College of Gastroenterology and chief of the GI division at Ann Arbor-based Michigan Medicine, told Becker’s that payer reimbursement policies are significantly limiting the adoption of new technologies, particularly in the endoscopy suite. “Providers are forced to work with payers individually for any reimbursement, and payers will often deem new technology as ’emerging’ or ‘experimental,'” he said “Then, they use it as rationale for denying coverage or providing an inadequate reimbursement for the practice’s expense…
Conducting clinical research as an early career gastroenterologist can take on many forms and has varying definitions of success. This article focuses on key factors to consider and should be supplemented with mentorship tailored to personal interests, goals, and institutional criteria for success. In this article, we will discuss selected high-yield topics that assist in early-career research. We will briefly discuss 1. Defining your niche, 2. Collaboration, 3. Visibility, 4. Time management, 5. Funding, 6. Receiving mentorship, and 7. Providing mentorship. We will conclude with discussing several authors’ experience in the research lab of the first author (FELD Lab –…
Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare providers in the US. This collaboration marks the starting phase of a programme aimed at improving access to the cancer test. The Quest Diagnostics connectivity system allows US providers to order the test directly.
Researchers at the Technical University of Munich and LMU University Hospital Munich have uncovered how exclusive enteral nutrition (EEN), a liquid diet used to manage Crohn’s disease, reduces inflammation by altering the gut microbiome. Their study found that medium-chain fatty acids in the formula promote beneficial gut bacteria, preventing inflammation. To extend the benefits of EEN, a clinical trial will test whether combining it with fecal microbiome transfer can sustain remission. If successful, this approach could revolutionize Crohn’s disease treatment by establishing a healthier, long-term gut microbiome.